Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 613 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 526-550 of 613 matching filings.

Per page
25
Current page
22
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Oct 2016
Reporting date
11 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Oct 2016
Reporting date
06 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
30 Sep 2016
Reporting date
29 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
26 Sep 2016
Reporting date
22 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
26 Sep 2016
Reporting date
21 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS 6-K

Filing date
26 Sep 2016
Reporting date
07 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

REPORT OF FOREIGN PRIVATE ISSUER DATED AUGUST 22, 2016

Filing date
22 Aug 2016
Reporting date
22 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
15 Aug 2016
Reporting date
15 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
15 Aug 2016
Reporting date
15 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

REPORT OF FOREIGN PRIVATE ISSUER DATED AUGUST 5, 2016

Filing date
05 Aug 2016
Reporting date
30 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
05 Aug 2016
Reporting date
05 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

REPORT OF FOREIGN PRIVATE ISSUER DATED JULY 29, 2016

Filing date
29 Jul 2016
Reporting date
29 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
29 Jul 2016
Reporting date
28 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
22 Jul 2016
Reporting date
22 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-206994

SUPPL

Filing date
22 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-206994

SUPPL

Filing date
15 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Jul 2016
Reporting date
11 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88628

SCHEDULE 13D

Filing date
05 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

REPORT OF FOREIGN PRIVATE ISSUER DATED JUNE 30, 2016

Filing date
30 Jun 2016
Reporting date
15 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
29 Jun 2016
Reporting date
28 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
22 Jun 2016
Reporting date
22 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
15 Jun 2016
Reporting date
15 Jun 2016
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
13 May 2016
Reporting date
12 May 2016
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
12 May 2016
Reporting date
11 May 2016
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .